Policy options for the drug pricing conundrum
Sign Up to like & getrecommendations! Published in 2025 at "Proceedings of the National Academy of Sciences of the United States of America"
DOI: 10.1073/pnas.2418540122
Abstract: Significance Proposed U.S. policies to reduce pharmaceutical prices, though particularly beneficial for low-income and elderly populations, could reduce firms’ investment in R&D. Social benefit cost ratios from pharmaceutical R&D are high, and the likely effect… read more here.
Keywords: options drug; pricing conundrum; policy options; drug pricing ... See more keywords